Literature DB >> 30391323

Neuronal serine racemase associates with Disrupted-In-Schizophrenia-1 and DISC1 agglomerates: Implications for schizophrenia.

Ariel A Jacobi1, Sarah Halawani2, David R Lynch3, Hong Lin4.   

Abstract

D-Serine, an endogenous coagonist of N-methyl-d-aspartate receptors (NMDARs) at the glycine binding site, is synthesized by serine racemase (SR) through conversion of l-Serine. Dysregulation of SR/D-Serine and Disrupted-In-Schizophrenia-1 (DISC1) contributes to the pathogenesis of schizophrenia at converging pathways, as perturbation of SR-DISC1 binding in astrocytes elicits schizophrenia-like behaviors in mice. However, an association of neuronal SR with DISC1 remains elusive. Here we report that SR associates with DISC1 and its agglomerates in cortical neurons, which can be modulated by NMDAR activity. Endogenous SR colocalizes with DISC1 large agglomerates in the soma and with smaller puncta in the nucleus and dendrites of cortical neurons. Co-immunoprecipitation assays demonstrate SR interaction with DISC1 in cortical neuronal lysates, suggesting the physiological presence of functional SR-DISC1 complexes in neurons. Moreover, exogenous d-Serine application significantly increases the interaction of SR with DISC1, the number of DISC1-SR large agglomerates and the levels of DISC1 agglomerated form along with SR in the triton-insoluble pellet fraction, whereas application of glycine with a glycine transporter inhibitor fails to increase their interactions, abundance of DISC1-SR large agglomerates and levels of DISC1 agglomerated form. This increase by d-Serine application is blocked by 7-chlorokynurenic acid, a specific antagonist at the glycine site of NMDARs, suggesting mediation through NMDARs. Our findings thus demonstrate neuronal SR association with DISC1 and its agglomerates, which can be modulated by d-Serine, thereby validating a novel neuronal SR-DISC1 complex responsive to NMDAR activation and providing a molecular mechanism by which pathways implicated in schizophrenia converge.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Agglomerates; Cortical neurons; Disrupted-In-Schizophrenia-1; NMDA receptor; Serine racemase; d-Serine

Mesh:

Substances:

Year:  2018        PMID: 30391323      PMCID: PMC6402792          DOI: 10.1016/j.neulet.2018.10.055

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  77 in total

1.  Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia.

Authors:  L A Glantz; D A Lewis
Journal:  Arch Gen Psychiatry       Date:  2000-01

2.  Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia.

Authors:  Nutan Kolluri; Zhuoxin Sun; Allan R Sampson; David A Lewis
Journal:  Am J Psychiatry       Date:  2005-06       Impact factor: 18.112

3.  High dose D-serine in the treatment of schizophrenia.

Authors:  Joshua T Kantrowitz; Anil K Malhotra; Barbara Cornblatt; Gail Silipo; Andrea Balla; Raymond F Suckow; Cyril D'Souza; John Saksa; Scott W Woods; Daniel C Javitt
Journal:  Schizophr Res       Date:  2010-06-11       Impact factor: 4.939

Review 4.  D-serine regulation of NMDA receptor activity.

Authors:  Herman Wolosker
Journal:  Sci STKE       Date:  2006-10-10

5.  Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes.

Authors:  N W Kleckner; R Dingledine
Journal:  Science       Date:  1988-08-12       Impact factor: 47.728

6.  D-serine and serine racemase are localized to neurons in the adult mouse and human forebrain.

Authors:  Darrick T Balu; Shunsuke Takagi; Matthew D Puhl; Michael A Benneyworth; Joseph T Coyle
Journal:  Cell Mol Neurobiol       Date:  2014-01-17       Impact factor: 5.046

7.  DISC1, astrocytes and neuronal maturation: a possible mechanistic link with implications for mental disorders.

Authors:  Meng Xia; Shanshan Zhu; Alexey Shevelkin; Christopher A Ross; Mikhail Pletnikov
Journal:  J Neurochem       Date:  2016-08       Impact factor: 5.372

8.  Mutant mice with reduced NMDA-NR1 glycine affinity or lack of D-amino acid oxidase function exhibit altered anxiety-like behaviors.

Authors:  Viviane Labrie; Steven J Clapcote; John C Roder
Journal:  Pharmacol Biochem Behav       Date:  2008-10-07       Impact factor: 3.533

9.  DISC1: Structure, Function, and Therapeutic Potential for Major Mental Illness.

Authors:  Dinesh C Soares; Becky C Carlyle; Nicholas J Bradshaw; David J Porteous
Journal:  ACS Chem Neurosci       Date:  2011-08-05       Impact factor: 4.418

Review 10.  Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders.

Authors:  Giles E Hardingham; Hilmar Bading
Journal:  Nat Rev Neurosci       Date:  2010-09-15       Impact factor: 34.870

View more
  4 in total

Review 1.  D-Serine, the Shape-Shifting NMDA Receptor Co-agonist.

Authors:  Joseph T Coyle; Darrick Balu; Herman Wolosker
Journal:  Neurochem Res       Date:  2020-03-18       Impact factor: 3.996

Review 2.  d-Amino Acids and pLG72 in Alzheimer's Disease and Schizophrenia.

Authors:  Yu-Jung Cheng; Chieh-Hsin Lin; Hsien-Yuan Lane
Journal:  Int J Mol Sci       Date:  2021-10-09       Impact factor: 5.923

3.  Tyrosine 121 moves revealing a ligandable pocket that couples catalysis to ATP-binding in serine racemase.

Authors:  Chloe R Koulouris; Sian E Gardiner; Tessa K Harris; Karen T Elvers; S Mark Roe; Jason A Gillespie; Simon E Ward; Olivera Grubisha; Robert A Nicholls; John R Atack; Benjamin D Bax
Journal:  Commun Biol       Date:  2022-04-11

Review 4.  Responsible Genes for Neuronal Migration in the Chromosome 17p13.3: Beyond Pafah1b1(Lis1), Crk and Ywhae(14-3-3ε).

Authors:  Xiaonan Liu; Sarah A Bennison; Lozen Robinson; Kazuhito Toyo-Oka
Journal:  Brain Sci       Date:  2021-12-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.